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ABSTRACT 
In recent years, there has been an exponential interest in the development of novel drug delivery systems using nanoparticles. Nanoparticles are 
defined as particulate dispersions or solid particles with size in the range of 10-1000nm. There has been a considerable research interest in the 
area of drug delivery using particulate delivery systems as carriers for small and large molecules. Particulate systems like nanoparticles have 
been used as a physical approach to alter and improve the pharmacokinetic and pharmacodynamic properties of various types of drug 
molecules. Nanoparticles have been extensively studied as particulate carriers in the pharmaceutical and medical fields, because they show 
promise as drug delivery systems as a result of their sustained and targeting release properties, subcellular size, biocompatibility with tissue and 
cells. Various polymers have been used in the formulation of nanoparticles for targeting drug delivery research to increase therapeutic benefit, 
while minimizing side effects. Polymeric nanoparticls with a size in the nanometer range protect drugs against in vitro and in vivo degradation. 
The use of nanoparticle drug delivery is a universal approach to increase the therapeutic performance of poorly soluble drugs  in any route of 
administration. In this review focused various aspects of nanoparticle formulation, characterization and their applications in targeting delivery.  
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INTRODUCTION 
The control drug delivery alters the pharmacokinetics and 
pharmacodynamics of drug substance in order to improve 
the therapeutic efficacy and safety. Besides more traditional 
matrix or reservoir drug delivery systems, colloidal drug 
delivery system has gained in more popularity1. Colloidal 
drug delivery systems offer a number of advantages over 
conventional dosage forms. Due to their small particle size, 
colloidal preparations lend themselves to parenteral 
preparations and may be useful as sustain release injections 
for the delivery to a specific organ or target site. The major 
colloidal drug delivery systems include liposome and 
nanoparticles2. 
Nanoparticles in pharmaceutical applications have gained 
plenty of research attention during recent decades. Although 
the research concerning formulation of nanoparticles into 
drug delivery devices has been extensive, only a few 
polymeric nanoparticulate products have reached the 
market. Among the drugs used in nanoparticle formulations, 
particularly cancer therapeutics is widely studied because 
the formulation might reduce toxicity of the drug while 
improving efficacy of the treatment3. In addition to drug 
molecules, other candidates to be encapsulated in or coupled 
with nanoparticles include macromolecules like proteins, 
peptides and genes (nucleic acids). These kinds of molecules 
tend to be inactivated in the body by enzymatic degradation. 
In terms of controlled release, nanoparticles provide 
protection against the body conditions resulting in sustained 
release and maintenance of bioactivity before the drug 
reaches the target4. 
Nanoparticles are colloidal polymeric particles of size below 
1μm with a therapeutic agent either dispersed in polymeric 
matrix or encapsulated in polymer. The term polymeric 
nanoparticle encompasses nanospheres and nanocapsules. 
Nanospheres are defined as a polymeric matrix in which the 
drug is uniformly dispersed and nanocapsules are described 
as a polymeric membrane that surrounds the drug in the 
matrix5. 
Advantages: These advantages include 
1. Targeted delivery of drugs to the specific site to minimize 
toxicity 
2. Improved bioavailability by reducing fluctuations in 
therapeutic ranges 
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3. Improved stability of drugs against enzymatic 
degradation 
4. Controlled release reduces dosing frequency with 
improved patience compliance.  
5. The small particle size also reduces potential irritant 
reactions at the injection site.  
MATERIALS USED FOR PREPARATION OF 
NANOPARTICLES 
A broad range of synthetic and natural polymers available 
for nanoparticle formation, but their biocompatibility and 
biodegradability are the major limiting factors for their use 
in the drug delivery area. Synthetic polymers, on the other 
hand, offer better reproducibility of the chemical 
characteristics of the synthesized nanoparticles as compared 
to the natural polymers  
Natural Polymers 
Various polymers have been used in the formulation of 
nanoparticles for drug delivery research to increase 
therapeutic benefit, while minimizing side effects. Natural 
polymers have been classified into polysaccharides and 
proteins. Proteins are gelatin; albumin, lecithin, legumin and 
vicillin. Polysaccharides are alginate, dextran, chitosan and 
pollulan6. 
A. Chitosan 
Chitosan is a modified natural carbohydrate polymer 
prepared by the partial N‐deacetylation of chitin, a natural 
biopolymer derived from crustacean shells such as crabs, 
shrimps and lobsters. Chitosan is also found in some 
microorganisms, yeast and fungi. After cellulose chitin is the 
second most abundant polysaccharide in nature. It is 
physically protected, non poisonous, biocatalyst and eco-
friendly polysaccharide7. Although chitin is insoluble in most 
solvents, chitosan is soluble in most organic acidic solutions 
at pH less than 6.5 including formic, acetic, tartaric, and citric 
acid. 
B. Gelatin 
Gelatin is one of the protein materials that can be used for 
the production of nanoparticles. It is obtained by controlled 
hydrolysis of the fibrous, insoluble protein, collagen, which is 
widely found as the major component of skin, bones and 
connective tissue. The interest was based on the facts that 
gelatin is biodegradable, non‐toxic, easy to crosslink and to 
modify chemically and has therefore an immense potential to 
be used for the preparation of colloidal drug delivery 
systems such as microspheres and nanoparticles7.  
C. Albumin 
Albumin is an good-looking macromolecular shipper and 
extensively use to arrange nanospheres and nanocapsules, 
due to its availability in pure form and its biodegradability, 
nontoxicity and nonimmunogenicity. On the other hand, 
albumin nanoparticles are biodegradable, easy to prepare in 
defined sizes, and carry reactive groups on their surfaces and 
also offer the advantage that ligands can easily be attached 
by covalent linkage8.  
D. Alginate 
Alginate, a naturally occurring copolymer of glucuronic acid 
and manuronic acid, is widely used for pharmaceutical 
applications. Specifically, the simple aqueous-based gel 
formation of sodium alginate in the presence of divalent 
cations such as Ca2+ has been used for drug delivery9. 
Alginate is anionic polysaccharide that it has been widely 
used in drug delivery High drug encapsulation efficiency was 
achieved in alginate nanoparticles, ranging from 70%‐90%.  
Synthetic Polymers 
Synthetic polymers offer better reproducibility of the 
chemical characteristics as compared to the natural 
polymers. Common classes of polymers used to encapsulate 
drugs in colloidal systems include polyamides, poly (amino 
acids), polyesters, polyorthoesters and polyanhydrides. 
A. Lactide and Glycolide copolymers  
Most popular biodegradable polymers used in drug delivery 
are polyester copolymers based on lactic and glycolic acids. 
Poly (d,l-lacticco-glycolic acid) (PLGA) is used for the 
manufacture of implants and internal sutures and is known 
to be biocompatible, degrading to produce the natural 
products lactic acid and glycolic acid4.  
B. Poly (ε-Caprolactones)  
PCL is a water permeable polymer with hydrophobic and 
high crystalline properties. It undergoes bulk erosion by 
random hydrolytic chain cleavage in the first phase, resulting 
in a decrease in the molecular weight of the polymer10.  
C. Polyanhydrides 
The hydrophobic and crystalline materials have been shown 
to undergo erosion by surface hydrolysis, minimizing water 
diffusion into the bulk of the delivery device. The monomeric 
anhydride bonds have extreme reactivity toward water and 
undergo hydrolysis to generate the dicarboxylic acids10. 
Although hydrolysis is catalyzed by both acid and base, an 
increase in pH enhances the rate of hydrolytic degradation. 
PREPARATION OF NANOPARTICLES 
The nanoparticles prepared by using following methods: 
Emulsification–solvent diffusion 
It is widely used method for preparing nanoparticles3. The 
drug and polymer dissolved in a partially water soluble 
solvent. Commonly used solvents are propylene carbonate, 
benzyl alcohol, ethyl acetate, isopropyl acetate, methyl 
acetate, methyl ethyl ketone, butyl lactate or isovaleric acid. 
The organic phase is saturated with water and is then diluted 
with an extensive amount of pure water to facilitate diffusion 
of the organic solvent from the organic phase droplets 
leading to the precipitation of the polymer as presented in 
Figure: 1. The aqueous phase may contain surfactants such 
as Pluronic, PVA and sodium taurocholate. Finally, the 
solvent is eliminated by evaporation. 
 
Figure 1: Schematic representation of the emulsification-
solvent diffusion method 
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Nanoprecipitation (Solvent diffusion method) 
The easiest and reproducible techniques for preparing 
nanospheres were the snanoprecipitation method. Three 
basic ingredients are needed for this method: polymer, 
polymer solvent and non-solvent for the polymer. In brief, 
both the polymer and drug are dissolved in a water miscible 
organic solvent of intermediate polarity5. The resulting 
organic phase is injected into a stirred aqueous phase 
containing a surfactant as stabilizer. The nanoparticles are 
formed instantaneously during the rapid diffusion of the 
organic phase into the aqueous phase as shown in Fig: 2, 
typically, this method is used for hydrophobic drug 
entrapment, but it has been adapted for hydrophilic drugs as 
well. Finally, the solvent is removed under reduced 
pressure10.
 
 
Figure 2: Schematic representation of the solvent displacement technique 
 
Oil in water emulsion method 
The method is based on the emulsification of an organic 
solution which contains the polymer and the active 
component in an aqueous phase, followed by the 
evaporation of the organic solvent5. Different surfactants can 
be dissolved in the aqueous phase. The size reduction of the 
emulsion droplet is done by sonication for miniemulsion 
formation. The evaporation step is required to eliminate the 
organic solvent present in the organic phase. This leads to 
the precipitation of the polymer as nanoparticles with a 
diameter in the nanometers range.  
 
 
Figure 3: schematic representation of o/w single-emulsion solvent evaporation method 
Polymerization method  
In this method, drug is incorporated either by being 
dissolved in the polymerization medium or by adsorption 
onto the nanoparticles after polymerization completed. The 
nanoparticle suspension is then purified to remove various 
stabilizers and surfactants employed for polymerization by 
ultracentrifugation and re-suspending the particles in an 
isotonic surfactant-free medium11. 
Coacervation or phase separation method 
This method involves a mixture of two aqueous phases, of 
which one is the polymer chitosan, a di-block co-polymer 
ethylene oxide or propyleneoxide and the other is a 
polyanion sodium tripolyphosphate12. In this method, 
positively charged amino group of chitosan interacts with 
negative charged tripolyphosphate to form coacervates with 
a size in the range of nanometer. 
CHARACTERIZATION OF NANOPARTICLES 
Particle size and surface morphology 
The scanning electron microscope (SEM) is one of the most 
versatile instruments widely applied to surface 
microstructure imaging. SEM is a type of electron 
microscopy that images the sample surface of a solid 
specimen by using a focused beam of high-energy electrons. 
Surface charge of the nanoparticles 
The Zeta potential of the nanoparticles was determined by 
Zetasizer12. Zeta potential is important parameter when 
considering the stability of the nanoparticles in vitro. The 
more negative or positive values of zeta potential are related 
to more stable particles; more repulsion between particles 
reduce the particle aggregation. 
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Table 1:  Zeta potential for colloids in water and their 
stability 
Zeta potential (mv) Stability behaviour of the colloid 
0 to +-5 Rapid coagulation/ flocculation 
From +-10 to +-20 Incipient instability 
From+-20 to +-40 Moderate stability 
From+-40 to +-60 Good stability    
More than +-61 Excellent stability 
 
Entrapment and loading efficiency 
Drug entrapment efficiency is a percentage value that 
describes the quantity of the drug material in the 
nanoparticles out of the total amount used in the process. 
The entrapment into the nanoparticles is described by two 
important parameters: theoretical drug loading, which is the 
ratio between mass of drug used in synthesis and mass of 
polymer used in synthesis, and nanoparticle recovery. The 
encapsulation efficiency was determined by using the 
following formula13 
                         ( )     
                          
                
      
The percentage drug loading capacity was determined using 
the following formula: 
                 
                                         
                   
      
Drug release study 
The characterization purposes and for quality control 
reasons, the determination of the in vitro release of drug 
from nanoparticles is important13. In case of micro and 
nanoparticulate systems, the apparatus are suitable as 
following: 
1. Side by side diffusion cells with artificial or biological 
membranes 
2. Dialysis bag diffusion technique 
3. Reverse dialysis sac technique 
4. Ultracentrifugation 
5. Ultra filtration (Centrifugal) technique  
APPLICATIONS OF NANOPARTICULATE DELIVERY 
SYSTEMS  
Tumor targeting delivery systems: Nanoparticles have 
able to deliver a concentrate dose of drug in the vicinity of 
the tumor targets via the enhanced permeability and 
retention effect or active targeting by ligands on the surface 
of nanoparticles14. Nanoparticles will reduce the drug 
exposure of healthy tissues by limiting drug distribution to 
target organ. 
Oral delivery of peptides and proteins: Polymeric 
nanoparticles allow encapsulation of bioactive molecules 
and protect them against enzymatic and hydrolytic 
degradation. For instance, it has been found that insulin-
loaded nanoparticles have preserved insulin activity and 
produced blood glucose reduction in diabetic rats for up to 
14 days following the oral administration14. 
Epithelial cells in the GI tract: Targeting strategies to 
improve the interaction of nanoparticles with adsorptive 
enterocytes and M-cells of Peyer’s patches in the GI tract can 
be classified into those utilizing specific binding to ligands or 
receptors and those based on nonspecific adsorptive 
mechanism15.  
Gene delivery: Nanoparticles loaded with plasmid DNA 
could also serve as an efficient sustained release gene 
delivery system due to their rapid escape from the 
degradative endo-lysosomal compartment to the 
cytoplasmic compartment14. 
Brain targeting delivery systems 
It has been reported poly (butylcyanoacrylate) nanoparticles 
was able to deliver hexapeptide dalargin, doxorubicin and 
other agents into the brain which is significant because of the 
great difficulty for drugs to cross the BBB15. 
CONCLUSION 
Nanoparticles can offer significant advantages over the 
conventional drug delivery in terms of high stability, high 
specificity, high drug carrying capacity, ability for controlled 
release, possibility to use in different route of administration 
and the capability to deliver both hydrophilic and 
hydrophobic drug molecules. Nanoparticle drug delivery also 
makes it possible for drugs to permeate through cell walls, 
which is of critical importance to the expected growth of 
genetic medicine over the next few years. 
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